Combination of Statins and NSAIDs as a Potential Novel Addition to the Limited Anti-Breast Cancer Weaponry: A True Synergistic Model

Asian Pacific Journal of Cancer Prevention
doi 10.31557/apjcp.2019.20.5.1295
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EpiSmart Science Vector Ltd

Related search

Largazole as a Novel and Selective Anti-Breast Cancer Agent

2011English

Breast Cancer: A New Imaging Approach as an Addition to Existing Guidelines

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2015English

Arsenic Sulfide as a Potential Anti-Cancer Drug

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Regorafenib in Combination With Silybin as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer

Oncotarget
Oncology
2017English

Ellagic Acid as a Potential Anti-Cancer Drug

International Journal of Radiology & Radiation Therapy
2017English

Optimized NSAIDs for Breast Cancer Prevention

2007English

Statins and Venous Thrombosis: A Story Too Good to Be True?

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2012English

Effect of Statins on Breast Cancer Recurrence and Mortality: A Review

Breast Cancer: Targets and Therapy
Oncology
2017English

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Breast Cancer Risk: Differences by Molecular Subtype

Cancer Causes and Control
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy